drugs glp 1 GLP-1 Agonists: A Comprehensive Overview As Interest in GLP-1 Drugs

During glucose regulation, activation of these receptors helps improve the function of -cells and protect the pancreas, enhancing insulin secretion and better controlling blood sugar levels

Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like tirzepatide and semaglutide but has increased efficacy

Scheme 27

MACE 4P, 4-point cardiovascular composite episode, including hospitalization due to non-stable angina

Recently, the STEP-HFpEF trial enrolled 529 non-diabetic patients with HFpEF and obesity, who were randomly assigned to receive either once-weekly semaglutide (2.4 mg) or placebo for 52 weeks

[DOI] [PubMed] [Google Scholar] 122.Neal B., Perkovic V., Mahaffey K.W., de Zeeuw D., Fulcher G., Erondu N